Posted in | News | Signal Processing

Exelis Awarded Contract to Supply ACaP Radar Jamming Pod for Tactical Aircraft

Exelis has received a $68 million multiyear indefinite-delivery, indefinite-quantity contract to continue supplying the Advanced Capability Pod (ACaP) to the U.S. Air Force and U.S. Navy for use on F-15, F-16 and F/A-18 tactical aircraft.

Designed by ELTA Systems Ltd. and produced by Exelis, the ACaP system provides the aircraft with a lightweight, cost-effective and fully integrated electronic radio frequency countermeasures capability. The system offers simultaneous receive and jam coverage against multiple concurrent threats, acting fully autonomously while allowing for aircrew intervention when manual control is required.

"The ACaP jamming pod is the most effective radar jammer in its class, offering pilots unparalleled electronic protection and the ability to counter advanced anti-access/area denial strategies in hostile, high-threat environments,” said Pete Martin, director of defense systems for the Exelis electronic attack & release systems business. "This award further demonstrates Exelis’ role as a global leader in electronic warfare."

The Exelis Electronic Systems division in Amityville, N.Y., provides the ACaP. Deliveries under the
latest contract are expected to begin in July 2014.

About Exelis

Exelis is a diversified, top-tier global aerospace, defense, information and services company that leverages a 50-year legacy of deep customer knowledge and technical expertise to deliver affordable, mission-critical solutions for global customers. We are a leader in critical networks, ISR and analytics, electronic warfare, navigation, sensors, air traffic solutions, communications, and information systems as have strong positions in composite aerostructures, logistics and technical services. Headquartered in McLean, Va., the company employs about 19,000 people and generated 2012 sales of $5.5 billion.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.